The clinical validation of gold-195m: a new short half-life radiopharmaceutical for rapid, sequential, first pass angiocardiography in patients.
D000328:Adult; D000368:Aged; D000790:Angiocardiography / Q000009:adverse effects / Q000379:methods; D009202:Cardiomyopathies / Q000000981:diagnostic imaging; D002986:Clinical Trials as Topic; D003486:Cyanides / Q000097:blood; D006046:Gold; D006207:Half-Life; D006352:Heart Ventricles / Q000000981:diagnostic imaging; D006801:Humans; D008297:Male; D008875:Middle Aged; D009200:Myocardial Contraction; D009203:Myocardial Infarction / Q000000981:diagnostic imaging*; D011868:Radioisotopes; D011877:Radionuclide Imaging; D013318:Stroke Volume; D013667:Technetium; D013861:Thiocyanates / Q000097:blood; D013997:Time Factors
D003486:Cyanides; D011868:Radioisotopes; D013861:Thiocyanates; D013667:Technetium; D006046:Gold